TRIM65 and hepatocellular carcinoma: In particular, the decreased proliferation ability induced by TRIM65 silencing was almost reversed by overexpression of wild‐type TRIM65 (TRIM65‐WT) but not of two mutants (Figure 3B–D), suggesting that TRIM65 contributes to proliferation based on its E3 ligase activity in HCC cells.